These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 16917962

  • 1. Parvovirus B19 and immune disorders.
    Pugliese A, Beltramo T, Torre D, Roccatello D.
    Cell Biochem Funct; 2007; 25(6):639-41. PubMed ID: 16917962
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].
    Uslu H, Kiki I, Ozbek A, Erdem F, Ayyildiz A.
    Mikrobiyol Bul; 2007 Oct; 41(4):597-602. PubMed ID: 18173080
    [Abstract] [Full Text] [Related]

  • 7. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P, Lehmann HW, Knöll A, Dorsch S, Modrow S.
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [Abstract] [Full Text] [Related]

  • 8. [Systemic manifestations of Parvovirus B19 infections].
    Sève P, Ferry T, Charhon A, Calvet A, Broussolle C.
    Rev Med Interne; 2004 Oct; 25(10):740-51. PubMed ID: 15471600
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].
    Türk Dağı H, Ozdemir M, Baykan M, Baysal B.
    Mikrobiyol Bul; 2010 Jul; 44(3):467-72. PubMed ID: 21063997
    [Abstract] [Full Text] [Related]

  • 11. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
    Regaya F, Khelifa R, Zouari R, Kchir M, Karoui M, Essid R.
    Arch Inst Pasteur Tunis; 2003 Jul; 80(1-4):9-15. PubMed ID: 15941063
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Seroprevalence of B19 parvovirus infection in patients with acute polyarthritis].
    Campoy Reolid E, Casanova Rituerto A, Rodríguez Moreno J, Gómez Vaquero C, Ros Expósito S, Roig Escofet D.
    Rev Clin Esp; 1996 Dec; 196(12):828-30. PubMed ID: 9132859
    [Abstract] [Full Text] [Related]

  • 16. Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway?
    Aslanidis S, Pyrpasopoulou A, Kontotasios K, Doumas S, Zamboulis C.
    Eur J Intern Med; 2008 Jul; 19(5):314-8. PubMed ID: 18549931
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Anti-GM1 and anti-sulphatide antibodies in systemic idiopathic vasculitis, systemic lupus erythematosus and mixed cryoglobulinaemia: Serum detection and clinical and electrophysiologic correlations].
    Alpa M, Ferrero B, Cavallo R, Naretto C, Gennaro M, Bellizia L, Sena LM, Roccatello D.
    G Ital Nefrol; 2002 Jul; 19(6):617-21. PubMed ID: 12508165
    [Abstract] [Full Text] [Related]

  • 19. Human parvovirus B19 infection in children: uncommon clinical presentations.
    Barash J, Dushnitzky D, Sthoeger D, Bardenstein R, Barak Y.
    Isr Med Assoc J; 2002 Oct; 4(10):763-5. PubMed ID: 12389336
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.